Could a spinal implant tame Hard-to-Control asthma?

NCT ID NCT07709754

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests whether a device that stimulates the spinal cord — called pulmonary neuromodulation — can improve asthma control in adults with moderate to severe asthma that remains uncontrolled despite high-dose inhalers or biologic medications. Participants receive the implanted device and are randomly assigned to have it activated immediately or after a delay. The main goal is to see if more people achieve a meaningful improvement in their Asthma Control Test score.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a spinal cord stimulation device (pulmonary neuromodulation)
What this could lead to
If effective, this device could offer a new option for people whose asthma remains poorly controlled despite standard medications.
What could go wrong
This is a small early feasibility study with only 30 participants, so results may not apply widely. The device requires surgical implantation, which carries risks such as infection or device-related complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE-TO-SEVERE ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Jewish Health

    Denver, Colorado, 80206, United States

    Contact

  • University of Florida

    Gainesville, Florida, 32611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.